Parameters | Control (n = 10) | Cervical cancer (n = 10) | Pure NDV (n = 10) | HA-TC-NDV (n = 10) | Range (unit) |
---|---|---|---|---|---|
RBC profile | Â | ||||
 RBC count | 5.8 ± 0.41 | 3.39 ± 0.20 | 2.96 ± 0.32 | 4.9 ± 0.24 | 4–5.9 × 1012/L |
 Hemoglobin | 15 ± 0.27 | 7.1 ± 0.15 | 7.5 ± 0.25 | 9.1 ± 0.71 | 12–16 × g/dL |
 Hematocrit | 45.98 ± 1.20 | 30.72 ± 2.1 | 30.93 ± 2.0 | 33 ± 1.63 | 35–50% |
 MCV | 47 ± 0.61 | 98.7 ± 0.39 | 87.64 ± 0.73 | 72.5 ± 0.41 | 40–60 fl |
 MCH | 25 ± 0.51 | 18.5 ± 0.35 | 15.3 ± 0.6 | 20.3 ± 0.38 | 21–31 pg |
 MCHC | 30 ± 0.47 | 48.4 ± 0.56 | 45.72 ± 0.45 | 42.3 ± 0.51 | 30–39% |
 Hemolysis | 2 ± 0 | 10.67 ± 0.3 | 24 ± 0.3 | 16.2 ± 0.4 | 0% |
 RBC morphology | Normal | Macrocytic | Normal | Normal | Normal |
WBC profile | Â | ||||
 WBC count | 7.4 ± 1.31 | 32.1 ± 2.5 | 9.0 ± 1.51 | 10.2 ± 0.51 | 4.5–11.0 × 103/µL |
 Neutrophils | 22 ± 1.86 | 16 ± 1.4 | 20 ± 1.33 | 23 ± 3.12 | 21–57% |
 Lymphocytes | 50 ± 3.0 | 94 ± 3.1 | 70 ± 3.61 | 59 ± 2.52 | 49–82% |
 Monocytes | 1.63 ± 0.51 | 9.7 ± 0.2 | 2.9 ± 0.51 | 2.68 ± 0.4 | 1.7–4.3% |
 Eosinophils | 2.31 ± 0.22 | 15 ± 0.17 | 3.9 ± 0.16 | 1.94 ± 0.64 | 0–3% |
 Basophils | 2.30 ± 0.17 | 0.22 ± 0.32 | 0.7 ± 0.31 | 2.14 ± 0.31 | 0–3% |
 WBC morphology | Normal | Abnormal | Abnormal | Abnormal | Normal |
Platelet profile | |||||
 Count | 380,000 ± 0.39 | 470,000 ± 0.47 | 320,000 ± 0.43 | 355,000 ± 0.36 | 150,000–450,000 μL |
 Morphology | Normal | Normal | Normal | Normal | Normal |
Kidney function test | |||||
 BUN | 16.23 ± 0.13 | 30 ± 0.44 | 26 ± 1.05 | 19 ± 0.29 | 18–29 mg/dL |
 Creatinine | 0.1 ± 0.02 | 0.35 ± 0.18 | 0.5 ± 0.19 | 0.35 ± 0.11 | 0.1–0.4 mg/dL |
Liver function test | |||||
 ALT | 19 ± 4.1 | 50 ± 3.15 | 25 ± 4.12 | 27 ± 4.72 | 4.1–36 U/L |
 AST | 13 ± 2.12 | 45 ± 3.4 | 30 ± 3.54 | 25.66 ± 4.17 | 8.1–33 U/L |
 ALP | 15 ± 1.67 | 47.1 ± 3.1 | 31 ± 2.27 | 36.33 ± 4.6 | 4.1–40 U/L |